All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F05%3A00004778" target="_blank" >RIV/00216208:11150/05:00004778 - isvavai.cz</a>

  • Result on the web

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial

  • Original language description

    The aim of the European First Episode Schizophrenia Trial (EUFEST) is to compare treatment with amisulpride, quetiapine, olanzapine and ziprasidone to a low dose of haloperidol in an unselected sample of first episode schizophrenia patients with minimalprior exposure to antipsychotics. At present, more than 400 patients have been recruited and randomized in the following countries: Austria, Belgium, Bulgaria, Czech Republic, Germany, France, Israel, Italy, the Netherlands, Poland, Rumania, Spain, Sweden and Switzerland: The study should be finished by the end of 2006 and it is expected that results will yield relevant clinical information with regard to the effectiveness of the second generation antipsychotics. This effort represents the first independently designed trans-European schizophrenia treatment trial.

  • Czech name

    Evropská studie u prvních epizod schizofrenie (EUFEST): zdůvodnění a záměr studie

  • Czech description

    Cíle: cílem the European first episode schizopherenia trial (EUFEST) je porovnání léčby amisulpridem, quetiapinem, olanzapinem a ziprasidonem s nízkými dávkami haloperidolu na vzorku pacientů po prvním ataku schizofrenie, kteří mají minimální předchozí zkušenosti s antipsychotiky. Do dnešní doby do studie vstoupilo více než 400 pacientů ze těchto zemí: Rakousko, Belgie, Bulharsko, Česká republika, Německo, Francie, Izrael, Itálie, Holandsko, Polsko, Rumunsko, atd. Studie by měla skončit na konci roku 2006.

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FL - Psychiatry, sexology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    S - Specificky vyzkum na vysokych skolach

Others

  • Publication year

    2005

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Schizophrenia Research

  • ISSN

    0920-9964

  • e-ISSN

  • Volume of the periodical

    78

  • Issue of the periodical within the volume

    2-3

  • Country of publishing house

    NL - THE KINGDOM OF THE NETHERLANDS

  • Number of pages

    10

  • Pages from-to

    147-156

  • UT code for WoS article

  • EID of the result in the Scopus database